Report Overview
Opioid drugs act on the opioid receptors present in the central and peripheral nervous system. The drug class primarily used in relieving pain includes natural, semi-synthetic, and synthetic opioids.Opioids can be administered as oral pills, parenteral, liquids, patches, or lozenges.
The global Opioids Agonist Drugs market size was estimated at USD 20110 million in 2023 and is projected to reach USD 26010.60 million by 2032, exhibiting a CAGR of 2.90% during the forecast period.
North America Opioids Agonist Drugs market size was estimated at USD 5503.84 million in 2023, at a CAGR of 2.49% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Opioids Agonist Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Opioids Agonist Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Opioids Agonist Drugs market in any manner.
Global Opioids Agonist Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Purdue Pharma
Titan pharmaceuticals
Boehringer Ingelheim
Janssen Pharmaceuticals
Inc
Sanofi
Sun Pharmaceuticals
Mallinckrodt Pharmaceuticals
Egalet Corporation
Endo Pharmaceuticals Inc.
Allergan
Plc
Pfizer Inc
Johnson & Johnson Services
Inc.
Hikma Pharmaceuticals PLC
Gr
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Opioids Agonist Drugs
1.2 Key Market Segments
1.2.1 Opioids Agonist Drugs Segment by Type
1.2.2 Opioids Agonist Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Opioids Agonist Drugs Market Overview
2.1 Global Market Overview
2.1.1 Global Opioids Agonist Drugs Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Opioids Agonist Drugs Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Opioids Agonist Drugs Market Competitive Landscape
3.1 Global Opioids Agonist Drugs Sales by Manufacturers (2019-2025)
3.2 Global Opioids Agonist Drugs Revenue Market Share by Manufacturers (2019-2025)
3.3 Opioids Agonist Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Opioids Agonist Drugs Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Opioids Agonist Drugs Sales Sites, Area Served, Product Type
3.6 Opioids Agonist Drugs Market Competitive Situation and Trends
3.6.1 Opioids Agonist Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Opioids Agonist Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Opioids Agonist Drugs Industry Chain Analysis
4.1 Opioids Agonist Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Opioids Agonist Drugs Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Opioids Agonist Drugs Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Opioids Agonist Drugs Sales Market Share by Type (2019-2025)
6.3 Global Opioids Agonist Drugs Market Size Market Share by Type (2019-2025)
6.4 Global Opioids Agonist Drugs Price by Type (2019-2025)
7 Opioids Agonist Drugs Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Opioids Agonist Drugs Market Sales by Application (2019-2025)
7.3 Global Opioids Agonist Drugs Market Size (M USD) by Application (2019-2025)
7.4 Global Opioids Agonist Drugs Sales Growth Rate by Application (2019-2025)
8 Opioids Agonist Drugs Market Consumption by Region
8.1 Global Opioids Agonist Drugs Sales by Region
8.1.1 Global Opioids Agonist Drugs Sales by Region
8.1.2 Global Opioids Agonist Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Opioids Agonist Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Opioids Agonist Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Opioids Agonist Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Opioids Agonist Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Opioids Agonist Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Opioids Agonist Drugs Market Production by Region
9.1 Global Production of Opioids Agonist Drugs by Region (2019-2025)
9.2 Global Opioids Agonist Drugs Revenue Market Share by Region (2019-2025)
9.3 Global Opioids Agonist Drugs Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Opioids Agonist Drugs Production
9.4.1 North America Opioids Agonist Drugs Production Growth Rate (2019-2025)
9.4.2 North America Opioids Agonist Drugs Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Opioids Agonist Drugs Production
9.5.1 Europe Opioids Agonist Drugs Production Growth Rate (2019-2025)
9.5.2 Europe Opioids Agonist Drugs Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Opioids Agonist Drugs Production (2019-2025)
9.6.1 Japan Opioids Agonist Drugs Production Growth Rate (2019-2025)
9.6.2 Japan Opioids Agonist Drugs Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Opioids Agonist Drugs Production (2019-2025)
9.7.1 China Opioids Agonist Drugs Production Growth Rate (2019-2025)
9.7.2 China Opioids Agonist Drugs Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Purdue Pharma
10.1.1 Purdue Pharma Opioids Agonist Drugs Basic Information
10.1.2 Purdue Pharma Opioids Agonist Drugs Product Overview
10.1.3 Purdue Pharma Opioids Agonist Drugs Product Market Performance
10.1.4 Purdue Pharma Business Overview
10.1.5 Purdue Pharma Opioids Agonist Drugs SWOT Analysis
10.1.6 Purdue Pharma Recent Developments
10.2 Titan pharmaceuticals
10.2.1 Titan pharmaceuticals Opioids Agonist Drugs Basic Information
10.2.2 Titan pharmaceuticals Opioids Agonist Drugs Product Overview
10.2.3 Titan pharmaceuticals Opioids Agonist Drugs Product Market Performance
10.2.4 Titan pharmaceuticals Business Overview
10.2.5 Titan pharmaceuticals Opioids Agonist Drugs SWOT Analysis
10.2.6 Titan pharmaceuticals Recent Developments
10.3 Boehringer Ingelheim
10.3.1 Boehringer Ingelheim Opioids Agonist Drugs Basic Information
10.3.2 Boehringer Ingelheim Opioids Agonist Drugs Product Overview
10.3.3 Boehringer Ingelheim Opioids Agonist Drugs Product Market Performance
10.3.4 Boehringer Ingelheim Opioids Agonist Drugs SWOT Analysis
10.3.5 Boehringer Ingelheim Business Overview
10.3.6 Boehringer Ingelheim Recent Developments
10.4 Janssen Pharmaceuticals
10.4.1 Janssen Pharmaceuticals Opioids Agonist Drugs Basic Information
10.4.2 Janssen Pharmaceuticals Opioids Agonist Drugs Product Overview
10.4.3 Janssen Pharmaceuticals Opioids Agonist Drugs Product Market Performance
10.4.4 Janssen Pharmaceuticals Business Overview
10.4.5 Janssen Pharmaceuticals Recent Developments
10.5 Inc
10.5.1 Inc Opioids Agonist Drugs Basic Information
10.5.2 Inc Opioids Agonist Drugs Product Overview
10.5.3 Inc Opioids Agonist Drugs Product Market Performance
10.5.4 Inc Business Overview
10.5.5 Inc Recent Developments
10.6 Sanofi
10.6.1 Sanofi Opioids Agonist Drugs Basic Information
10.6.2 Sanofi Opioids Agonist Drugs Product Overview
10.6.3 Sanofi Opioids Agonist Drugs Product Market Performance
10.6.4 Sanofi Business Overview
10.6.5 Sanofi Recent Developments
10.7 Sun Pharmaceuticals
10.7.1 Sun Pharmaceuticals Opioids Agonist Drugs Basic Information
10.7.2 Sun Pharmaceuticals Opioids Agonist Drugs Product Overview
10.7.3 Sun Pharmaceuticals Opioids Agonist Drugs Product Market Performance
10.7.4 Sun Pharmaceuticals Business Overview
10.7.5 Sun Pharmaceuticals Recent Developments
10.8 Mallinckrodt Pharmaceuticals
10.8.1 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Basic Information
10.8.2 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Product Overview
10.8.3 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Product Market Performance
10.8.4 Mallinckrodt Pharmaceuticals Business Overview
10.8.5 Mallinckrodt Pharmaceuticals Recent Developments
10.9 Egalet Corporation
10.9.1 Egalet Corporation Opioids Agonist Drugs Basic Information
10.9.2 Egalet Corporation Opioids Agonist Drugs Product Overview
10.9.3 Egalet Corporation Opioids Agonist Drugs Product Market Performance
10.9.4 Egalet Corporation Business Overview
10.9.5 Egalet Corporation Recent Developments
10.10 Endo Pharmaceuticals Inc.
10.10.1 Endo Pharmaceuticals Inc. Opioids Agonist Drugs Basic Information
10.10.2 Endo Pharmaceuticals Inc. Opioids Agonist Drugs Product Overview
10.10.3 Endo Pharmaceuticals Inc. Opioids Agonist Drugs Product Market Performance
10.10.4 Endo Pharmaceuticals Inc. Business Overview
10.10.5 Endo Pharmaceuticals Inc. Recent Developments
10.11 Allergan
10.11.1 Allergan Opioids Agonist Drugs Basic Information
10.11.2 Allergan Opioids Agonist Drugs Product Overview
10.11.3 Allergan Opioids Agonist Drugs Product Market Performance
10.11.4 Allergan Business Overview
10.11.5 Allergan Recent Developments
10.12 Plc
10.12.1 Plc Opioids Agonist Drugs Basic Information
10.12.2 Plc Opioids Agonist Drugs Product Overview
10.12.3 Plc Opioids Agonist Drugs Product Market Performance
10.12.4 Plc Business Overview
10.12.5 Plc Recent Developments
10.13 Pfizer Inc
10.13.1 Pfizer Inc Opioids Agonist Drugs Basic Information
10.13.2 Pfizer Inc Opioids Agonist Drugs Product Overview
10.13.3 Pfizer Inc Opioids Agonist Drugs Product Market Performance
10.13.4 Pfizer Inc Business Overview
10.13.5 Pfizer Inc Recent Developments
10.14 Johnson and Johnson Services
10.14.1 Johnson and Johnson Services Opioids Agonist Drugs Basic Information
10.14.2 Johnson and Johnson Services Opioids Agonist Drugs Product Overview
10.14.3 Johnson and Johnson Services Opioids Agonist Drugs Product Market Performance
10.14.4 Johnson and Johnson Services Business Overview
10.14.5 Johnson and Johnson Services Recent Developments
10.15 Inc.
10.15.1 Inc. Opioids Agonist Drugs Basic Information
10.15.2 Inc. Opioids Agonist Drugs Product Overview
10.15.3 Inc. Opioids Agonist Drugs Product Market Performance
10.15.4 Inc. Business Overview
10.15.5 Inc. Recent Developments
10.16 Hikma Pharmaceuticals PLC
10.16.1 Hikma Pharmaceuticals PLC Opioids Agonist Drugs Basic Information
10.16.2 Hikma Pharmaceuticals PLC Opioids Agonist Drugs Product Overview
10.16.3 Hikma Pharmaceuticals PLC Opioids Agonist Drugs Product Market Performance
10.16.4 Hikma Pharmaceuticals PLC Business Overview
10.16.5 Hikma Pharmaceuticals PLC Recent Developments
10.17 Gr
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Opioids Agonist Drugs Market Size Comparison by Region (M USD)
Table 5. Global Opioids Agonist Drugs Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global Opioids Agonist Drugs Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Opioids Agonist Drugs Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Opioids Agonist Drugs Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioids Agonist Drugs as of 2022)
Table 10. Global Market Opioids Agonist Drugs Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Opioids Agonist Drugs Sales Sites and Area Served
Table 12. Manufacturers Opioids Agonist Drugs Product Type
Table 13. Global Opioids Agonist Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Opioids Agonist Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Opioids Agonist Drugs Market Challenges
Table 22. Global Opioids Agonist Drugs Sales by Type (K MT)
Table 23. Global Opioids Agonist Drugs Market Size by Type (M USD)
Table 24. Global Opioids Agonist Drugs Sales (K MT) by Type (2019-2025)
Table 25. Global Opioids Agonist Drugs Sales Market Share by Type (2019-2025)
Table 26. Global Opioids Agonist Drugs Market Size (M USD) by Type (2019-2025)
Table 27. Global Opioids Agonist Drugs Market Size Share by Type (2019-2025)
Table 28. Global Opioids Agonist Drugs Price (USD/MT) by Type (2019-2025)
Table 29. Global Opioids Agonist Drugs Sales (K MT) by Application
Table 30. Global Opioids Agonist Drugs Market Size by Application
Table 31. Global Opioids Agonist Drugs Sales by Application (2019-2025) & (K MT)
Table 32. Global Opioids Agonist Drugs Sales Market Share by Application (2019-2025)
Table 33. Global Opioids Agonist Drugs Sales by Application (2019-2025) & (M USD)
Table 34. Global Opioids Agonist Drugs Market Share by Application (2019-2025)
Table 35. Global Opioids Agonist Drugs Sales Growth Rate by Application (2019-2025)
Table 36. Global Opioids Agonist Drugs Sales by Region (2019-2025) & (K MT)
Table 37. Global Opioids Agonist Drugs Sales Market Share by Region (2019-2025)
Table 38. North America Opioids Agonist Drugs Sales by Country (2019-2025) & (K MT)
Table 39. Europe Opioids Agonist Drugs Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific Opioids Agonist Drugs Sales by Region (2019-2025) & (K MT)
Table 41. South America Opioids Agonist Drugs Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa Opioids Agonist Drugs Sales by Region (2019-2025) & (K MT)
Table 43. Global Opioids Agonist Drugs Production (K MT) by Region (2019-2025)
Table 44. Global Opioids Agonist Drugs Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Opioids Agonist Drugs Revenue Market Share by Region (2019-2025)
Table 46. Global Opioids Agonist Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America Opioids Agonist Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe Opioids Agonist Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan Opioids Agonist Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China Opioids Agonist Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. Purdue Pharma Opioids Agonist Drugs Basic Information
Table 52. Purdue Pharma Opioids Agonist Drugs Product Overview
Table 53. Purdue Pharma Opioids Agonist Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. Purdue Pharma Business Overview
Table 55. Purdue Pharma Opioids Agonist Drugs SWOT Analysis
Table 56. Purdue Pharma Recent Developments
Table 57. Titan pharmaceuticals Opioids Agonist Drugs Basic Information
Table 58. Titan pharmaceuticals Opioids Agonist Drugs Product Overview
Table 59. Titan pharmaceuticals Opioids Agonist Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 60. Titan pharmaceuticals Business Overview
Table 61. Titan pharmaceuticals Opioids Agonist Drugs SWOT Analysis
Table 62. Titan pharmaceuticals Recent Developments
Table 63. Boehringer Ingelheim Opioids Agonist Drugs Basic Information
Table 64. Boehringer Ingelheim Opioids Agonist Drugs Product Overview
Table 65. Boehringer Ingelheim Opioids Agonist Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 66. Boehringer Ingelheim Opioids Agonist Drugs SWOT Analysis
Table 67. Boehringer Ingelheim Business Overview
Table 68. Boehringer Ingelheim Recent Developments
Table 69. Janssen Pharmaceuticals Opioids Agonist Drugs Basic Information
Table 70. Janssen Pharmaceuticals Opioids Agonist Drugs Product Overview
Table 71. Janssen Pharmaceuticals Opioids Agonist Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 72. Janssen Pharmaceuticals Business Overview
Table 73. Janssen Pharmaceuticals Recent Developments
Table 74. Inc Opioids Agonist Drugs Basic Information
Table 75. Inc Opioids Agonist Drugs Product Overview
Table 76. Inc Opioids Agonist Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 77. Inc Business Overview
Table 78. Inc Recent Developments
Table 79. Sanofi Opioids Agonist Drugs Basic Information
Table 80. Sanofi Opioids Agonist Drugs Product Overview
Table 81. Sanofi Opioids Agonist Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 82. Sanofi Business Overview
Table 83. Sanofi Recent Developments
Table 84. Sun Pharmaceuticals Opioids Agonist Drugs Basic Information
Table 85. Sun Pharmaceuticals Opioids Agonist Drugs Product Overview
Table 86. Sun Pharmaceuticals Opioids Agonist Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 87. Sun Pharmaceuticals Business Overview
Table 88. Sun Pharmaceuticals Recent Developments
Table 89. Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Basic Information
Table 90. Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Product Overview
Table 91. Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 92. Mallinckrodt Pharmaceuticals Business Overview
Table 93. Mallinckrodt Pharmaceuticals Recent Developments
Table 94. Egalet Corporation Opioids Agonist Drugs Basic Information
Table 95. Egalet Corporation Opioids Agonist Drugs Product Overview
Table 96. Egalet Corporation Opioids Agonist Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 97. Egalet Corporation Business Overview
Table 98. Egalet Corporation Recent Developments
Table 99. Endo Pharmaceuticals Inc. Opioids Agonist Drugs Basic Information
Table 100. Endo Pharmaceuticals Inc. Opioids Agonist Drugs Product Overview
Table 101. Endo Pharmaceuticals Inc. Opioids Agonist Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 102. Endo Pharmaceuticals Inc. Business Overview
Table 103. Endo Pharmaceuticals Inc. Recent Developments
Table 104. Allergan Opioids Agonist Drugs Basic Information
Table 105. Allergan Opioids Agonist Drugs Product Overview
Table 106. Allergan Opioids Agonist Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 107. Allergan Business Overview
Table 108. Allergan Recent Developments
Table 109. Plc Opioids Agonist Drugs Basic Information
Table 110. Plc Opioids Agonist Drugs Product Overview
Table 111. Plc Opioids Agonist Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 112. Plc Business Overview
Table 113. Plc Recent Developments
Table 114. Pfizer Inc Opioids Agonist Drugs Basic Information
Table 115. Pfizer Inc Opioids Agonist Drugs Product Overview
Table 116. Pfizer Inc Opioids Agonist Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 117. Pfizer Inc Business Overview
Table 118. Pfizer Inc Recent Developments
Table 119. Johnson and Johnson Services Opioids Agonist Drugs Basic Information
Table 120. Johnson and Johnson Services Opioids Agonist Drugs Product Overview
Table 121. Johnson and Johnson Services Opioids Agonist Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 122. Johnson and Johnson Services Business Overview
Table 123. Johnson and Johnson Services Recent Developments
Table 124. Inc. Opioids Agonist Drugs Basic Information
Table 125. Inc. Opioids Agonist Drugs Product Overview
Table 126. Inc. Opioids Agonist Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 127. Inc. Business Overview
Table 128. Inc. Recent Developments
Table 129. Hikma Pharmaceuticals PLC Opioids Agonist Drugs Basic Information
Table 130. Hikma Pharmaceuticals PLC Opioids Agonist Drugs Product Overview
Table 131. Hikma Pharmaceuticals PLC Opioids Agonist Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 132. Hikma Pharmaceuticals PLC Business Overview
Table 133. Hikma Pharmaceuticals PLC Recent Developments
Table 134. Gr?nenthal Opioids Agonist Drugs Basic Information
Table 135. Gr?nenthal Opioids Agonist Drugs Product Overview
Table 136. Gr?nenthal Opioids Agonist Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 137. Gr?nenthal Business Overview
Table 138. Gr?nenthal Recent Developments
Table 139. AbbVie Inc. Opioids Agonist Drugs Basic Information
Table 140. AbbVie Inc. Opioids Agonist Drugs Product Overview
Table 141. AbbVie Inc. Opioids Agonist Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 142. AbbVie Inc. Business Overview
Table 143. AbbVie Inc. Recent Developments
Table 144. Global Opioids Agonist Drugs Sales Forecast by Region (2025-2032) & (K MT)
Table 145. Global Opioids Agonist Drugs Market Size Forecast by Region (2025-2032) & (M USD)
Table 146. North America Opioids Agonist Drugs Sales Forecast by Country (2025-2032) & (K MT)
Table 147. North America Opioids Agonist Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 148. Europe Opioids Agonist Drugs Sales Forecast by Country (2025-2032) & (K MT)
Table 149. Europe Opioids Agonist Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 150. Asia Pacific Opioids Agonist Drugs Sales Forecast by Region (2025-2032) & (K MT)
Table 151. Asia Pacific Opioids Agonist Drugs Market Size Forecast by Region (2025-2032) & (M USD)
Table 152. South America Opioids Agonist Drugs Sales Forecast by Country (2025-2032) & (K MT)
Table 153. South America Opioids Agonist Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 154. Middle East and Africa Opioids Agonist Drugs Consumption Forecast by Country (2025-2032) & (Units)
Table 155. Middle East and Africa Opioids Agonist Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 156. Global Opioids Agonist Drugs Sales Forecast by Type (2025-2032) & (K MT)
Table 157. Global Opioids Agonist Drugs Market Size Forecast by Type (2025-2032) & (M USD)
Table 158. Global Opioids Agonist Drugs Price Forecast by Type (2025-2032) & (USD/MT)
Table 159. Global Opioids Agonist Drugs Sales (K MT) Forecast by Application (2025-2032)
Table 160. Global Opioids Agonist Drugs Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Opioids Agonist Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Opioids Agonist Drugs Market Size (M USD), 2019-2032
Figure 5. Global Opioids Agonist Drugs Market Size (M USD) (2019-2032)
Figure 6. Global Opioids Agonist Drugs Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Opioids Agonist Drugs Market Size by Country (M USD)
Figure 11. Opioids Agonist Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Opioids Agonist Drugs Revenue Share by Manufacturers in 2023
Figure 13. Opioids Agonist Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Opioids Agonist Drugs Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Opioids Agonist Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Opioids Agonist Drugs Market Share by Type
Figure 18. Sales Market Share of Opioids Agonist Drugs by Type (2019-2025)
Figure 19. Sales Market Share of Opioids Agonist Drugs by Type in 2023
Figure 20. Market Size Share of Opioids Agonist Drugs by Type (2019-2025)
Figure 21. Market Size Market Share of Opioids Agonist Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Opioids Agonist Drugs Market Share by Application
Figure 24. Global Opioids Agonist Drugs Sales Market Share by Application (2019-2025)
Figure 25. Global Opioids Agonist Drugs Sales Market Share by Application in 2023
Figure 26. Global Opioids Agonist Drugs Market Share by Application (2019-2025)
Figure 27. Global Opioids Agonist Drugs Market Share by Application in 2023
Figure 28. Global Opioids Agonist Drugs Sales Growth Rate by Application (2019-2025)
Figure 29. Global Opioids Agonist Drugs Sales Market Share by Region (2019-2025)
Figure 30. North America Opioids Agonist Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America Opioids Agonist Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Opioids Agonist Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada Opioids Agonist Drugs Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico Opioids Agonist Drugs Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Opioids Agonist Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe Opioids Agonist Drugs Sales Market Share by Country in 2023
Figure 37. Germany Opioids Agonist Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France Opioids Agonist Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. Opioids Agonist Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy Opioids Agonist Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia Opioids Agonist Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific Opioids Agonist Drugs Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Opioids Agonist Drugs Sales Market Share by Region in 2023
Figure 44. China Opioids Agonist Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan Opioids Agonist Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea Opioids Agonist Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India Opioids Agonist Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia Opioids Agonist Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America Opioids Agonist Drugs Sales and Growth Rate (K MT)
Figure 50. South America Opioids Agonist Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Opioids Agonist Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina Opioids Agonist Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia Opioids Agonist Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa Opioids Agonist Drugs Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Opioids Agonist Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Opioids Agonist Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE Opioids Agonist Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt Opioids Agonist Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria Opioids Agonist Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa Opioids Agonist Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global Opioids Agonist Drugs Production Market Share by Region (2019-2025)
Figure 62. North America Opioids Agonist Drugs Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe Opioids Agonist Drugs Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan Opioids Agonist Drugs Production (K MT) Growth Rate (2019-2025)
Figure 65. China Opioids Agonist Drugs Production (K MT) Growth Rate (2019-2025)
Figure 66. Global Opioids Agonist Drugs Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Opioids Agonist Drugs Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Opioids Agonist Drugs Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Opioids Agonist Drugs Market Share Forecast by Type (2025-2032)
Figure 70. Global Opioids Agonist Drugs Sales Forecast by Application (2025-2032)
Figure 71. Global Opioids Agonist Drugs Market Share Forecast by Application (2025-2032)
